Stress function index, a novel index for risk stratification and prognosis using stress echocardiography.
OBJECTIVE
The purpose of the study was to define an appropriate parameter for risk stratification and prognosis of patients undergoing stress echocardiography.


BACKGROUND
Among stress echocardiography variables, peak wall-motion score index (WMSI) and ejection fraction (EF) have been shown to be independent and significant predictors of cardiovascular morbidity and mortality. Data on the impact and importance of each parameter in risk stratification and prognosis are limited.


METHODS
We evaluated 1560 patients (59 +/- 13 years; 51% men) undergoing stress echocardiography (36% treadmill, 64% dobutamine). Peak WMSI was derived from the cumulative sum of 16 left ventricular segments divided by sum of visualized segments at peak stress. The ratio of peak WMSI to EF was calculated for the entire cohort. Based on this ratio and using the receiver operating characteristic curve, patients were divided into 3 groups: low- (< 1.9), intermediate- (1.9-3.1), and high- (> 3.1) risk subgroups. Follow-up (2.8 +/- 1.1 years) for confirmed myocardial infarction (n = 26) and cardiac death (n = 38) were obtained.


RESULTS
Stress echocardiography effectively risk stratified patients into low- (0.7%/y), intermediate- (2.0%/y), and high- (4.4%/y) risk subgroups (P < .0001) based on the ratio of peak WMSI to EF. Cox proportional hazard model showed that risk stratification based on the ratio of peak WMSI to EF (global chi2 = 106.05; P < .0001) provided incremental value beyond that provided by risk stratification by peak WMSI (global chi2 = 79.23; P < .0001) or risk stratification by EF alone (global chi2 = 87.12; P < .0001).


CONCLUSIONS
The ratio of peak WMSI to EF (stress function index) provides best incremental prognostic value and effectively risk stratifies patients into low-, intermediate-, and high-risk subgroups and is better than risk stratification by either peak WMSI or EF alone. The results of stress echocardiography should routinely combine peak WMSI and EF for effective risk stratification.
Bangalore
Sripal
S
Division of Cardiology, Department of Medicine, St Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York 10025, USA.
Yao
Siu-Sun
SS
Chaudhry
Farooq A
FA
D004280:Dobutamine; D004452:Echocardiography / Q000379:methods / Q000706:statistics & numerical data*; D005080:Exercise Test / Q000379:methods / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D014665:Vasodilator Agents; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000453:epidemiology*
D014665:Vasodilator Agents; D004280:Dobutamine